IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER

Recurrent T Lymphoblastic Leukemia/Lymphoma

University of Washingtonmonoclonal_antibodyPhase 2Dormant

CCC

53/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 38/ 100
Competitive Position: 89/ 100

Competitive context

49 Active assets in the Recurrent T Lymphoblastic Leukemia/Lymphoma cohort.

Asset / Sponsor	Phase	Rating
PREDNISONE TABLETS Children's Oncology Group	Phase 3	BB
Cyclophosphamide Children's Oncology Group	Phase 3	BB
Cytosin-Arabinosid Princess Maxima Center for Pediatric Oncology	Phase 3	BB
ETOPOSIDE Children's Cancer Group, China	Phase 3	BB
Daunorubicin Children's Oncology Group	Phase 3	B

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:

Recurrent Adult Burkitt LymphomaDormant

BBB

Indicative ·

78 / 100

View asset →

Recurrent Adult Diffuse Small Cleaved Cell LymphomaDormant

BBB

Indicative ·

76 / 100

View asset →

lymphoblastic lymphomaDormant

BBB